Stay updated on GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Sign up to get notified when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.

Latest updates to the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a government funding notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates current operating status and references official sources.SummaryDifference13%
- Check22 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%
- Check36 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.SummaryDifference0.8%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.8%
- Check50 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related details have been removed.SummaryDifference7%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.